McGill Cares: Building your team for unplanned life transitions
Join us on May 7th at noon for the next McGill Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.
Cross-pollinating ideas at the SCSD Research Day
Student presenters at the SCSD Research Day, which took place on February 21, 2025.
AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.
Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro
Free, online training program strengthens training and brings specialized care to communities across QuebecA healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.
Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Scaringi Lecture Series in Speech Language Pathology - Research Talk
Research Talk Thursday April 3, 2025, 4:30 to 6:00 pm 2001 McGill College Ave. Room 606
Project to create AI model for ALS receives Génome Québec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers
Achievements of clinicians and scientists recognized with King Charles III Coronation Medals
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.
Prescribing anti-swelling drug reduces immune response weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
McGill researchers receive funding from the Canadian Cancer Society for cancer equity research
Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee, from McGill's Department of Epidemiology, Biostatistics, and Occupational Health, have been awarded $449,604 from the Canadian Cancer Society’s
Six principal investigators from The Neuro receive CIHR grants
Projects include important research on Parkinson’s, glioblastoma and dementia
SCSD Research Day
Friday February 21st 2025 • 3pm to 5pm Leacock Building #232, 855 Sherbrooke West
Sunsetting of the Vanier and Banting programs
In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering and Research Council (NSERC), and the S